# CABOT CORP (CBT) · Edgar & Edgarette company card

> Cabot (CBT) saw revenue fall 7.0% in FY2025 to $3.7 billion, operating margin 16.7% against a -0.2% median for miscellaneous chemical products, equity 40.6% of assets, and dividend per share up 4 years running. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 16040 · fiscal year ended 2025-09-30 · 5 audited years read · [page](https://www.pops4.com/boards/company/CBT) · [JSON](https://www.pops4.com/boards/company/CBT.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $3.7B |
| Revenue growth, 1 year | -7.0% |
| Revenue growth per year | 2.2% |
| Operating margin | 16.7% (prior year 15.4%) |
| Net margin | 10.1% |
| Operating cash flow | $665M |
| Capital spending | $274M |
| Free cash flow | $391M |
| Cash | $258M |
| Long-term debt | $1.1B |
| Total assets | $3.8B |
| Total equity | $1.6B |
| Equity ÷ assets | 40.6% |
| Return on equity | 24.3% |
| Dividend per share | $1.76 |
| Dividend years rising | 4 |

## Readings, computed from those figures

- Altman Z: 4.38 (safe zone)
- Piotroski F: 6 of 9 (solid)
- Beneish M: -2.94 (below the −1.78 line)
- Health Harbor boat: Sound ship · one warning sign · slow and jumpy: growing slower than its size class, with revenue that swings more
- Cash Compass: Fading · slow and jumpy, lagging its peers

## Edgarette's reading

Exposure: revenue $3.7B (FY2025), total debt $1.1B. Experience: revenue down 7.0% on the year, up 2.2% a year over 4 years; operating margin 16.7%, up from 15.4%. Soundness: equity 40.6% of assets, return on equity 24.3%, payout 25.5% of profit, dividend per share up 4 years running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $2.8B and $4.1B next year (method v4.1: its own 4-year record of growth weighed at 50% against $1B–10B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $2.5B to $4.7B. A statistical range, not company guidance. Against peers (224 filers, $50M+ revenue, its industry group): operating margin 16.7% against a -0.2% median; growth -7.0% against 6.7%.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 3, latest 2026-09-15 ([filing](https://www.sec.gov/Archives/edgar/data/16040/000119312526391407/0001193125-26-391407-index.htm))

## Recent filings

- 8-K · filed 2026-11-02 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/16040/000119312526443873/0001193125-26-443873-index.htm)
- 8-K · filed 2026-09-15 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/16040/000119312526391407/0001193125-26-391407-index.htm)
- 8-K · filed 2026-08-21 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/16040/000119312526361109/0001193125-26-361109-index.htm)
- 8-K · filed 2026-08-14 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/16040/000119312526352348/0001193125-26-352348-index.htm)
- 10-Q · filed 2026-08-04 · [filing](https://www.sec.gov/Archives/edgar/data/16040/000119312526332489/0001193125-26-332489-index.htm)
- 8-K · filed 2026-08-03 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/16040/000119312526330708/0001193125-26-330708-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000016040.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=16040

## Cite

POPS4, Edgar & Edgarette: CABOT CORP (CBT) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/CBT. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.